Determination of Nitrosamines in Active Pharmaceutical Ingredients
Applications | 2020 | Agilent TechnologiesInstrumentation
LC/MS, LC/MS/MS, LC/QQQ
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Key wordsnitrosamine, accuracy, ndba, nitrosamines, nmor, nmea, ndpa, ndea, ultivo, ndma, npip, valsartan, pharmaceutical, gti, nitroso, dose, nitrosodimethylamine, prime, npyr, genotoxic, daily, impurities, solvent, intake, rsd, drug, dibutylamine, loq, nitrosomethylethylamine, nitrosomorpholine, agilent, api, nitrosodiethylamine, average, impurity, apis, propylamine, masshunter, flushing, describes, medicine, high, duration, dna, determination, excess, apci, combination, agency, ingredients
Similar PDF
Highly sensitive and robust LC-HRAM-MS method for simultaneous quantitation of sixteen nitrosamines in multiple drug products
2023|Thermo Fisher Scientific|Applications
Application note | 001657 Pharma Highly sensitive and robust LC-HRAM-MS method for simultaneous quantitation of sixteen nitrosamines in multiple drug products Goal Authors Krishna Mane , Venkatesh Chanukuppa , The aim of this study was to evaluate and report on…
Key words
prm, prmnipma, nipmannea, nneanitroso, nitrosonda, ndandpha, ndphanitrosamine, nitrosaminenmpa, nmpanmor, nmormetformin, metforminnmba, nmbanmea, nmeanpyr, npyrnpip, npipneipa
Determination of Nitrosamine Impurities Using the Agilent 6495D Triple Quadrupole LC/MS System
2023|Agilent Technologies|Applications
Application Note Determination of Nitrosamine Impurities Using the Agilent 6495D Triple Quadrupole LC/MS System Authors Abstract Lee Bertram and Linfeng Wu Agilent Technologies, Inc. Nitrosamine impurities are byproducts produced in trace amounts during the manufacture of pharmaceutical drugs. These impurities…
Key words
fragile, fragilenitrosamine, nitrosaminenpyr, npyrnmor, nmorresponses, responsesndma, ndmanmea, nmeanpip, npipndpa, ndpandba, ndbandea, ndealosartan, losartandrug, drugacquisition, acquisitionmin
Determination of Nitrosamine Impurities Using the Agilent 6475 Triple Quadrupole LC/MS System
2023|Agilent Technologies|Applications
Application Note Pharma/Biopharma Determination of Nitrosamine Impurities Using the Agilent 6475 Triple Quadrupole LC/MS System Authors Linfeng Wu and Lee Bertram Agilent Technologies, Inc. Santa Clara, CA, U.S. Shan-An Chan Agilent Technologies, Inc. Taiwan Abstract Nitrosamine impurities are by-products that…
Key words
nitrosamine, nitrosaminenmor, nmorresponses, responsesndma, ndmanmea, nmeanpyr, npyrnpip, npipndpa, ndpandba, ndbandea, ndeacounts, countsconcentration, concentrationlosartan, losartanblocker, blockerdrug
ASMS: Improvement Upon a Multi-Residue Method for Nitrosamine Analysis in Losartan Drug Product Using an Enhanced LC/MS/MS System
2023|Agilent Technologies|Posters
Poster Reprint ASMS 2023 Poster number TP 732 Improvement Upon a Multi-Residue Method for Nitrosamine Analysis in Losartan Drug Product Using an Enhanced LC/MS/MS System Bertram Lee1, Linfeng Wu1, Shan-An Chan2 and Winnie Huang3 1Agilent Technologies, Inc., Santa Clara, CA,…
Key words
nitrosamine, nitrosaminenmor, nmorresponses, responsesnmea, nmeanpyr, npyrnpip, npipndpa, ndpandea, ndeandma, ndmandba, ndbalosartan, losartanconcentration, concentrationacquisition, acquisitiondrug, drugimpurities